Global Endoluminal Suturing Devices Market Size study & Forecast, by Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Surgery, Other Surgeries), by End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Other)

Global Endoluminal Suturing Devices Market Size study & Forecast, by Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Surgery, Other Surgeries), by End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Other) and Regional Analysis, 2022-2029

Global Endoluminal Suturing Devices Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Therapeutic therapies using bariatric endoscopy to combat obesity, which affects millions of people worldwide and has now become a global pandemic, are steadily has become the preferred option in a variety of healthcare settings. Devices for suturing and stapling are mostly used in medical procedures related to GERD and obesity. The primary benefit is that these devices' implementation allows for minimally invasive clinical treatments. Due to significant advancements, clinical trials and treatments have traditionally advanced at a slower rate than in recent years. For endoscopic procedures, physicians frequently use endoluminal suturing devices, which are used to put thick sutures in the intended area with the aid of flexible sutures. A tiny, specialized suturing device used in endoscopic surgery that has flexibility. Endoluminal suturing devices provide a higher rate of recovery and satisfy demand for minimally invasive medical procedures, which improves patient experience and results in faster recovery times, fewer hospital visits, and shorter stays in hospitals. The acceptability of endoluminal suturing devices has also been aided by the use of advanced instruments. The key factors driving the market growth are rising minimally invasive operations, growing demand for surgeries, and growing cases of chronic diseases.

The increasing number of surgical procedures globally is creating a lucrative demand for the market during forecast period. Open surgeries, endoscopy, abdominal surgeries, and other gastrointestinal surgeries frequently use endoluminal suturing devices. The affordability and accessibility of surgical treatment have improved over time, which has resulted in a large increase in the number of surgical procedures involving suturing devices. The demand for cutting-edge surgical equipment, including suturing devices, has expanded further as a result of the rising prevalence of lifestyle illnesses and the ensuing increase in surgical procedures. According to Statista, in 2019, the minimally invasive surgery market globally was valued at USD 20.5 billion and it is anticipated to reach USD 44.04 billion by 2030. Also, the World Health Organization (WHO) reported that 235 million major surgeries were performed annually over the world in 2019. Additionally, rising adoption of outpatient surgeries is creating a lucrative opportunity for the market during forecast period. However, the difficulties of using the devices and high cost of Endoluminal Suturing Devices stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Endoluminal Suturing Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of large patient pool for surgery and favorable reimbursement policies in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as government concentration on improving healthcare infrastructure and increasing number of population prone to chronic disease and infectious diseases would create lucrative growth prospects for the Endoluminal Suturing Devices market across Asia Pacific region.

Major market players included in this report are:
Apollo Endosurgery, Inc.
Johnson & Johnson
Medtronic Plc
Cook Group Incorporated
USGI Medical
Ovesco Endoscopy AG
Endo Tools Therapeutics S.A.
ErgoSuture
Sutrue Ltd.
Stryker Corporation

Recent Developments in the Market:
In Dec. 2020, Apollo Endo-surgery, Inc. announced that Reshape Lifesciences would buy its surgical product line for laparoscopic bariatric surgery. Apollo's variety of endo-bariatric products will increase as a result.

Global Endoluminal Suturing Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Application, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Application:
Bariatric Surgery
Gastrointestinal Surgery
Gastroesophageal Reflux Disease Surgery
Other Surgeries

By End-User:
Hospitals
Clinics
Ambulatory Surgical Centers
Other

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned
Apollo Endosurgery, Inc.
Johnson & Johnson
Medtronic Plc
Cook Group Incorporated
USGI Medical
Ovesco Endoscopy AG
Endo Tools Therapeutics S.A.
ErgoSuture
Sutrue Ltd.
Stryker Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.